Shinto L, Quinn J, Montine T, Dodge HH, Woodward W, Baldauf-Wagner S, Waichunas D, Bumgarner L, Bourdette D, Silbert L, Kaye J (2014) A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimers disease
Source: PubChem Sequence : YLRIVQCRSVEGSCGF Length : 16 amino acids Disulfide Bridge : Cys7Cys15 Formula : CHNOS Monoisotopic Mass : ~1,813.86 Da (native), ~1,929.92 Da (alkylated) IUPAC Name : Detailed stereochemical descriptor SMILES : Linear chemical chain encoding AOD9604 is studied in experimental models as a tool compound for investigating metabolic signaling and adipose tissue biology
The manufacturer, Eli Lilly, currently holds patent rights that prevent other companies from making a generic
BYVASDA (bevacizumab biosimilar injection), SULINNO, and HALPRYZA (rituximab biosimilar injection) are not approved products in the United States